NovaBay Pharmaceuticals Inc (NYSE MKT LLC:NBY)

0.52
Delayed Data
As of Feb 26
 -0.03 / -5.45%
Today’s Change
0.50
Today|||52-Week Range
1.38
-17.46%
Year-to-Date
No recent news for NovaBay Pharmaceuticals Inc.

Today’s Trading

Previous close0.55
Today’s open0.55
Day’s range-- - --
Volume181,716
Average volume (3 months)128,712
Market cap$28.4M
Dividend yield--
Data as of 02/26/2015

Growth & Valuation

Earnings growth (last year)-75.00%
Earnings growth (this year)+28.57%
Earnings growth (next 5 years)--
Revenue growth (last year)-49.95%
P/E ratioNM
Price/Sales13.51
Price/Book2.88

Competitors

 Today’s
change
Today’s
% change
ECTEEcho Therapeutics In...+0.11+4.78%
--Synergy Strips Corp0.000.00%
REPHRecro Pharma Inc0.000.00%
PPHMPPeregrine Pharmaceut...+0.82+3.77%
Data as of 02/26/2015

Financials

Next reporting dateMarch 31, 2015
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$3.5M
Annual profit (last year)-$16.0M
Net profit margin-461.37%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Ramin Najafi
CFO, CAO, Secretary &
Treasurer
Thomas J. Paulson
Corporate headquarters
Emeryville, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account